Skip to contentM
Medtronic plc
M
MDTMedtronic plc Q3 2026 · 10-Q
Revenue$9.02B$9.02B+8.7% vs Q3 2025 Net Income$1.14B$1.14B−11.7% vs Q3 2025 EPS Diluted$0.89$0.89−11.9% vs Q3 2025 Operating Income$1,464,000,000−11.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medtronic plc · CIK 1613103 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,300,000,000+9.7% Margins · derivedOperating margin16.2%−3.6 pt vs Q3 2025
Net margin12.7%−2.9 pt vs Q3 2025
ended Jan 23, 2026 · filed Feb 24, 2026 · 32 d after period end